According to Wired magazine, "Since the mid-2000s, clinics have been selling expensive, unproven stem-cell treatments to any patient desperate enough to believe their claims of cures for everything from arthritis to autism." These clinics have "been tied to serious infections, several cases of blindness, and one patient’s death." Leigh Turner, a professor at the Center for Bioethics, a Consortium member, has authored several major research papers on the growing availability of questionable stem-cell therapies. Turner notes that despite greater FDA scutiny, which includes an "increase the rule changes and the public hearings and more inspections and warning letters and the lawsuits, the market is still expanding at a rapid rate.” A recent Pro Publica/New Yorker investigation provides additional details of the promotional methods and dubious science that ensnares consumers in these dangerous interventions.
Tuesday, June 18, 2019